U.S. federal trademark · Serial No. 97826210
pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene and cell therapy products, namely, monoclonal antibodies, bi-specifics antibodies, chimeric antigen receptors, and synthetic receptor proteins, pharmaceuticals, and pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer
drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, gene and cell therapy, and oncology; providing scientific, pharmaceutical, clinical and medical research information via the internet; research and development consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; pharmaceutical, scientific, medical and clinical research and development services; drug discovery services provided through a computational platform engine used for research and development in the field of drugs
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.